David Arkowitz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David arkowitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Arkowitz Today - Breaking & Trending Today

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Welcome to the Seres Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Kevin Mannix, Head of Investor Relations. Please go ahead. Kevin Mannix: […] ....

Joseph Thome , David Arkowitz , Eric Shaff , Nestle Health Science , Profitable Airbnb Cities , Football Leagues , Nestle Health Science , Seres Therapeutics ,

Seres secures first approval of oral microbiome product

Seres, together with partners Nestle Health Science, receive approval for its microbiome therapeutic to prevent recurrence of C. difficile infection. ....

David Arkowitz , Nestle Health Science , Drug Administration , Seres Therapeutic , Oaktree Capital , Markets Amp Regulations , Live Biotherapeutics , Nestle Health Science ,

Oaktree Provides $250MM Term Loan Facility to Seres Therapeutics - News

Seres Therapeutics, a leading microbiome therapeutics company, entered into a new $250 million senior secured debt facility ("Term Loan Facility") provided by funds managed by Oaktree Capital Management. The Company drew the first tranche of $110 million at closing, with three additional tranches available. These additional tranches include $90. ....

Aman Kumar , David Arkowitz , Sullivan Cromwell , Latham Watkins , Morgan Stanley Co , Life Sciences Lending At Oaktree , Company At Oaktree , Seres Therapeutics , Oaktree Capital , Term Loan Facility , Chief Financial Officer , Co Portfolio Manager , Life Sciences Lending ,